China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dupilumab for Moderate-to-Severe Eczema: Efficacy and Safety in Real-World Use'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132823

Registration Time: 2026/09/18

Type: Observational study

Primary Sponsor: The Second Affiliated Hospital of Xi'an Jiaotong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=304582

Published by HT Digital Content Services with permission from Health Daily Digest....